🇺🇸 FDA
Pipeline program

AIM-CHD Mobile Health Intervention

2024-GSP-GG-4

Unknown other completed

Quick answer

AIM-CHD Mobile Health Intervention for Secondary Prevention of Coronary Heart Disease is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Secondary Prevention of Coronary Heart Disease
Phase
Unknown
Modality
other
Status
completed

Clinical trials